SUMMARY. Alterations of circulating thyroid hormones are frequently present in chronic nonthyroidal illnesses and may predict prognosis. Pulmonary tuberculosis, a common treatable debilitating disease, may provide a useful model for detailed evaluation of changes of thyroid hormones in relation to subsequent recovery or mortality. Over a period of 12 months, we performed a prospective study of 40 consecutive Chinese patients aged over 50 years and admitted with newly diagnosed pulmonary tuberculosis. Blood samples were drawn for serial thyroid function tests [free thyroxine (T 4 ) , free triiodothyronine (T 3 ) and thyroid-stimulating hormone] before treatment and at I, 2 and 4 months afterwards. Mortality was determined up to 12 months of follow-up. The euthyroid sick syndrome occurred in 63% of patients at presentation. Twelve of 25 euthyroid sick patients died as compared to one of 15 patients with normal baseline thyroid function tests (P<0·02). Among euthyroid sick patients, those who died had significantly lower free T 3 concentration at presentation than those who survived (P<Oo05). An undetectable free T 3 concentration at presentation was associated with a subsequent mortality of 75% (9 of 12). Of the survivors, all patients demonstrated a significant rise in serum free T 4 concentrations following treatment, which was apparent by 1 month. These data suggest that an undetectable free T 3 concentration at presentation reflects severity of illness and predicts a subsequent high mortality.
Additional key phrases: non-thyroidal illness; free thyroxine; free triiodothyronine; thyrotropin It is well recognized that alterations of circulating thyroid hormone concentrations occur in a variety of nonthyroidal illnesses. 1,2 The changes are characterized by reduction in serum total triiodothyronine (T 3 ) as well as free T 3 concentrations, Serum total thyroxine (T 4 ) concentrations may be reduced, elevated or normal; free T 4 concentrations vary depending on assay methodology and are difficult to interpret. 3 Despite these changes, most patients remain clinically euthyroid and have a relatively normal basal serum thyroid-stimulating hormone (TSH) concentration with a normal or blunted response to thyrotropin-releasing hormone (TRH); hence the term euthyroid sick syndrome. 1, 2 Pulmonary tuberculosis remains a significant problem in many developing countries and an Correspondence: Dr C C Chow. upsurge of tuberculosis, partly related to acquired immunodeficiency syndrome has recently been observed in many industrial societies." Pulmonary tuberculosis is a chronic debilitating disease, which, although treatable, still carries a high mortality particularly in the elderly.5,6 Thus, pulmonary tuberculosis provides a potential model for the study of changes of thyroid hormones associated with euthyroid sick syndrome. We have followed prospectively thyroid hormone concentrations, before and after treatment, in 40 Chinese patients with newly diagnosed active pulmonary tuberculosis.
SUBJECTS AND METHODS

Subjects
Forty Chinese patients (30 men, 10 women) aged over 50 years (mean age 73 years, range 51-86) with newly diagnosed pulmonary tuberculosis were studied. Thirty-three patients (830/0) had parenchymal tuberculosis (26 smear positive and all culture positive). Seven had tuberculosis pleural effusions, in which caseating granulomata identified in pleural biopsy or a positive culture of tubercle bacilli on pleural aspirate were considered diagnostic. Patients with known neurological, hypothalamic-pituitary or thyroid disease were excluded. None of the patients were receiving medications known to interfere with thyroid hormone metabolism (such as iodide, lithium, corticosteroids, dopamine, dobutamine, (3-blockers, and phenytoin).
All patients were treated with conventional antituberculous chemotherapy including streptomycin (or ethambutol), isoniazid, rifampicin and pyrizinamide in accordance with recommended guidelines. Initial treatment was supervised and monitored in hospital. Patients who were stable after initial treatment were either transferred to a convalescent chest hospital or discharged. Discharged patients were reassessed monthly as outpatients up to the completion of treatment at 6 months or more.
Blood samples were drawn, with informed consent, for thyroid function tests before treatment and at 1,2 and 4 months afterwards. Euthyroid sick syndrome was diagnosed on the basis of clinical euthyroidism, low free T 3 concentrations « 3 . 3 pmollL) with a lack of significant elevation of TSH, and variable changes in free T 4 • Mortality was determined up to 12 months of follow-up (range 6-12 months).
Assays
The serum TSH concentration was measured by an immunochemiluminometric assay (Ciba Corning Diagnostics, Norwood, MA, USA) with a detection limit of 0·02 mUlL. Serum free T 3 and T 4 concentrations were determined by commercial immunoassay kits (Amerlex-M, Amersham Corporation, Arlington Heights, IL, USA for T 3 and Gammacoat two step assay, Baxter, Cambridge, MA, USA for T 4 ) . The analytical coefficients of variations of the methods were 6·4%, 4·8%, and 7· 5% for TSH, free T3 and free T4' respectively. Reference ranges are shown in Table I .
Statistical analysis
All data are presented as the mean and standard error of the mean (SEM). Student's paired t-test and two-tailed Wilcoxon rank sum tests were used for comparison of groups where appropriate. Statistical comparisons of ratios were performed using the x 2 test. P values of less than 0·05 were considered to indicate statistical significance. Table I summarizes the clinical characteristics and baseline hormone concentrations of subjects with normal thyroid function tests and subjects with euthyroid sick syndrome at presentation. Twenty-five subjects (63%) had euthyroid sick syndrome. The age and duration of illness were similar in both groups of subjects. However, euthyroid sick syndrome subjects were predominantly male (22 of 25, P<0·05). Mean serum concentrations of free T 3 , as expected, were lower in the euthyroid sick syndrome subjects (P<O·OOI), and TSH was higher T AHLE I. Clinical characteristics and baseline hormone concentrations ofsubjects with normal thyroid function and subjects with euthyroid sick syndrome at presentation. Results are mean (SEM) 
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·P<0·05 compared with survivors (Wilcoxon rank sum test). TSH = Thyroid stimulating hormone.
(P< 0,005). No difference between both groups of subjects was found in the mean serum free T 4 concentration. Mortality in the euthyroid sick syndrome subjects (12 of 25) was higher (P< 0,05) than in subjects with normal baseline thyroid function (I of 15).
Since the euthyroid sick syndrome was associated with a much higher mortality, we further analysed this group of subjects by subdividing them into two categories: those who died and those who survived ( Table 2) . No differences were found between the subjects who died and those who survived for the mean serum concentrations of TSH and free T4' However, mean (SEM) serum free T) concentration remained significantly lower (P< O' 05) in the deceased euthyroid sick syndrome subjects [1' 2 (0'1) pmol/L] than that of the surviving euthyroid sick syndrome subjects [2'0 (0'2) pmol/L].
Nine of 13 subjects who died during the study period had a pretreatment free T) concentration below the detection limit (Table 3) , whereas only three of 13 euthyroid sick syndrome who survived had undetectable free T) (data not shown). Thus, an undetectable serum free T] at presentation is associated with high mortality (9 of 12). Serum free T 4 concentrations were variable although most were within the reference range ( Table 3 ). All but one patient (patient 26) had a normal TSH. The median survival of 13 patients (12 euthyroid sick syndrome, one normal baseline thyroid function) who died during treatment for pulmonary tuberculosis was 14 days (range 3-82) from the commencement of antituberculous drugs.
Longitudinal thyroid hormone profdes in survivors
Both normal baseline thyroid function and euthyroid sick syndrome subjects who survived 20·3  1·05  14  7  85  <1·0  18·9  1·85  12  14  77  <1·0  9·8  0·43  48  15  75  <1·0  21·6  0·82  34  19  70  2·2  19·2  1·01  12  20  75  3·9  22·8  0·71  58  25  68  <1·0  12·2  1·90  3  26  72  < 1·0  4·4  5·14  4  36  76  1·7  23·9  1·99  78  37  74  1·7  13·4  1·52  7  39  70  <1·0  15·2  0·48  5  40  77  <1·0  17·8  0·87  30 Reference range 3,3-8,2 7,0-21,8 0,3-4,0 TSH = Thyroid stimulating hormone.
DIISCUSSION
In this study, we have shown that euthyroid sick syndrome is frequently present (63070) in hospitalized pulmonary tuberculosis patients aged over 50 years. As in previous reports.t-" a high mortality (33070) was observed despite carefully supervised antituberculosis treatment. The occurrence of euthyroid sick syndrome at presentation indicates more severe illness within this group of patients and equates with clinical outcome. Patients with euthyroid sick syndrome were predominantly male and almost half (48070) died. More than 90070 of deaths were associated with euthyroid sick syndrome at presentation. An undetectable serum free T) concentration before treatment predicted a subsequent mortality of 75070 among our patients. Serum free T 4 , however, did not differentiate between survivors and non-survivors. Previous studies measuring total thyroid hormone have indicated that the combination of reduced serum total T) and T 4 concentrations (low T) and low T 4 syndrome) occurs in patients with more severe illness and indicates a poor prognosis.>" However, most of these studies investigated change of thyroid function in heterogeneous groups of patients with a variety of illnesses. When free T 4 values are measured, normal, elevated or reduced levels are found and are difficult to interpret. 2,) Recent studies involving relatively homogeneous patient groups show that total or free T) concentrations are more closely related to severity and clinical outcome. Simons et al. reported that euthyroid sick syndrome is very common among hospitalized elderly patients, and a low serum T) concentration correlates with severity of illness and mortality in hospital. 10 Hamilton et al. in a study of 84 hospitalized patients with chronic advanced heart P<O·OOI and P<0·05, respectively); 19·9 (l'O)pmol/L to 13·7(l·I)pmol/L at month 4 in the surviving euthyroid sick syndrome subjects (P<0·05)]. Serum TSH concentrations increased in the normal baseline thyroid funtion subjects [0'9 (0'1) mUlL to 1·1 (0'2) mUlL at month 1 and 1·3 (0'2) mUlL at month 4; both P<0·05)], but not significantly in the surviving euthyroid sick syndrome subjects. Two survivors had transient mild elevation of serum TSH on recovery (peak 4· 52 and 6·81 mUlL, respectively), and two had marginally low serum TSH at presentation (both 0·26 mUlL). showed a rise in serum concentrations of free T) and TSH, with a gradual fall in free T 4 on recovery with antituberculosis treatment (Fig. I) . Mean (SEM) serum concentrations of free T) rose significantly in both groups of subjects during follow-up [4· 5 (0' 2) pmol/L to 5·5 (0'4)pmol/L at month 2 and 5·5 (0'4)pmol/L at month 4 in the normal baseline thyroid function subjects (P<O'OOI and P<O'01, respectively); 1· 9 (0' 2) pmol/L to 4· 2 (0' 3) pmol/L at month 1, 4· 2 (0' 4) pmol/L at month 2 and 4· 9 (0' 3) pmol/L at month 4 in the surviving euthyroid sick syndrome subjects (all P<O·OOI)]. Simultaneously, serum concentrations of free T 4 fell significantly in both groups [17' 0 (0' 6) pmol/L to 14· 0 (0' 8) pmol/L at month 1, 13· 5 (0' 7) pmol/L at month 2 and 15· 3 (0' 7) pmol/L at month 4 in the normal baseline thyroid functions subjects (P<0·05, failure, demonstrated that a low freelreverse T] ratio is associated with poor clinical outcome while the free T 4 index is normal in all patients. I I LoPresti and Nicoloff reported that, in human immunodeficiency virus infected patients with life-threatening Pneumocystis carinii pneumonia, a fatal outcome is associated with persistent undetectable serum T] values. Thus, an extremely low serum total or free T] value reflects the severity of illness in a variety of chronic debilitating illness, while the serum free T 4 value is of little predictive value.
In contrast to two previous reports.Pv'" biochemical secondary hypothyroidism, as defined by both subnormal T 4 and TSH values was rarely encountered in our euthyroid sick syndrome patents. We observed borderline subnormal TSH concentrations in only three of 25 euthyroid sick syndrome patients and all had a normal free T4' Only one patient (No. 26) had a low free T 4 concentration (4' 4 pmollL) associated with a mildly elevated TSH (5 ·14 mUlL). Our findings are in agreement with recent studies by Faber et al. and Romijn et al. when confounding variables such as dopamine and exogenous steroids were excluded from the study populaticn.P'I? Thus, unrecognized central nervous system tuberculosis involvement as an explanation of the observed thyroid dysfunction in our patients is unlikely.
The mechanism by which euthyroid sick syndrome develops in non-thyroidal illness is not known. In this study, free T] concentrations were lower, and TSH values higher, in patients with euthyroid sick syndrome. Mean free T 4 levels were within the high normal range in both groups of patients and were elevated in six patients at presentation. These observations support the view that euthyroid sick syndrome develops as a consequence of altered thyroid hormone metabolism in non-thyroidal illness. First, a decrease in peripheral conversion of T 4 to T], as indicated by previous studies, would account for the reduction in circulating free T] together with a normal or elevated free T 4 concentration.!'!" It has been suggested that a thyroid-binding inhibitor may alter the availability of T 4 for metabolism and inhibit iodothyronine 5/ -monodeiodinase (type I), mainly in liver and kidney. IS Profound suppression of enzyme activity with more severe illness would produce very low circulating free T] concentrations. Secondly, the lower than expected rise in TSH in response to reduced circulating free T] in euthyroid sick syndrome patients could be explained by stable or even increased intrapituitary 5/ -monodeiodinase (type II) activity. 19, 20 An intrapituitary euthyroid state could then be maintained by increased conversion of circulating T 4 to T]. Alternatively, increased concentrations of circulating agents such as glucocorticoids and catecholamine may act at a suprapituitary level to inhibit TSH secretion in non-thyroidal illness. 2 1 , 22 Recently described evidence of humoral links between the immune and endocrine systems 2 ] ,24 may help to explain the genesis of the observed hormonal changes in inflammatory conditions such as pulmonary tuberculosis. Interleukin-l (IL-I), secreted by activated lymphocytes, induces hypothalamic corticotropin-releasing hormone release with consequent pituitary-adrenal stimulation. IL-l also releases vasopressin, which may further stimulate adrenocorticotropic hormone release. Additionally, IL-I triggers a cascade of other cytokines, principally IL-2, IL-6 and tumour necrosis factor which also activate the hypothalamic-pituitary-adrenal axis. TSH release is also suppressed directly by IL-I and tumour necrosis factor, or indirectly by stimulation of somatostatin secretion, 25 Longitudinal follow-up of survivors shows that a rise in TSH was apparent after I month of treatment and was accompanied by a rise in free T] and gradual fall in free T 4 concentrations in both normal baseline thyroid function and euthyroid sick syndrome patients, although a more marked change was seen in the latter. Two patients (Nos 9 and 28) showed transient mild elevation of TSH during recovery, as previously described.P The correction of hormonal disturbances within 1-2 months of antituberculosis treatment coincides with the normalization of an initial highly-elevated soluble IL-2 receptor concentration."
In our study, all patients received rifampicin as a component of their antituberculosis treatment. Ohnhaus et al. have shown that rifampicin, a potent inducer of liver microsomal enzyme activity, lowers total T 4 , free T 4 and reverse T] concentrations.P-" It may also increase T] at higher dosage, as a result of enhanced peripheral conversion of T 4 and T]. Theoretically, this may hasten the recovery from euthyroid sick syndrome after antituberculosis treatment. However, it is doubtful whether any significant effect on thyroid hormone metabolism would be observed at the dosages used (450-600 mg/ day).
CONCLUSION
This study shows that euthyroid sick syndrome occurs commonly in pulmonary tuberculosis patients aged over 50. An undetectable serum free T 3 concentration reflects severity and subsequent mortality. On recovery with treatment, free T 3 rises in parallel with TSH, but free T 4 falls.
